Asml Holding Nv · EURONEXT:ASML

Asml Holding Nv — Q4 2012 Earnings Presentation

30 slides from Asml Holding Nv's earnings presentation, Jan 17, 2013

  1. Slide 1: ASML plans 2013 at sales level similar to 2012

    ASML plans 2013 at sales level similar to 2012 ASML 2012 Fourth Quarter and 2012 Annual Results Veldhoven, the Netherlands January 17, 2013

  2. Slide 2: Forward looking statements

    Forward looking statements Public Slide 2 17 January 2013 “Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, including expected sales trends

  3. Slide 3: Important Information for Investors and Stockholders

    Important Information for Investors and Stockholders Public Slide 3 This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any 17 January 2013 vote or approval. No offer of securities shall be made except by means of a prosp

  4. Slide 4: • Business summary • Cymer merger update • Business environment

    Public Slide 4 17 January 2013 • Business summary • Cymer merger update • Business environment • ASML technology status • Customer Co-Investment Program update • Outlook

  5. Slide 5: Business summary

    Public Slide 5 17 January 2013 Business summary

  6. Slide 6: Q4 results - highlights

    Q4 results - highlights Public Slide 6 17 January 2013 • Net sales of € 1,023 million, 34 systems sold valued at € 767 million, net service and field option sales at € 257 million • Gross margin of 41.1% • Operating margin of 18.1% • Net bookings of € 667 million, 32 systems • Backlog at € 1,214 mil

  7. Slide 7: Net Sales

    Total net sales M€ Public Slide 7 17 January 2013 6000 5,651 5000 1,211 4,732 4,508 1,023 4000 3,768 1,521 1,459 Q1 Net Sales 955 2,954 1,229 Q2 3000 494 Q3 934 1,176 Q4 697 1,529 2000 1,596 1,228 930 844 581 1,069 1000 555 1,452 1,252 949 919 742 277 0 183 2007 2008 2009 2010 2011 2012 Numbers have

  8. Slide 8: Net system sales breakdown in value: Q4 2012

    Net system sales breakdown in value: Q4 2012 Public Slide 8 Total value is € 767 million 17 January 2013 Technology End-Use Foundry 76% KrF 19% ArF dry 3% Memory 13% I-Line 2% Region IDM 11% Taiwan ArF Immersion 55% 76% Sales in Units Europe 4% 16 14 China 1% Due to uncertainty around system Singapo

  9. Slide 9: Consolidated statements of operations M€

    Consolidated statements of operations M€ Public Slide 9 17 January 2013 Q3 12 Q4 12 2011 2012 Net sales 1,229 1,023 5,651 4,732 Gross profit 531 420 2,449 2,005 Gross margin % 43.2% 41.1% 43.3% 42.4% R&D costs 144 155 590 589 SG&A costs 70 80 218 259 Income from operations 317 185 1,641 1,157 Operat

  10. Slide 10: Key financial trends 2011 – 2012

    Key financial trends 2011 – 2012 Public Slide 10 Consolidated statements of operations M€ 17 January 2013 Q4 11 Q1 12 Q2 12 Q3 12 Q4 12 Net sales 1,211 1,252 1,228 1,229 1,023 Gross profit 496 524 530 531 420 ASML released € 120 Gross margin % 41.0% 41.8% 43.2% 43.2% 41.1% million of liability for u

  11. Slide 11: Cash flows M€

    Cash flows M€ Public Slide 11 Q3 12 Q4 12 2011 2012 17 January 2013 Net income 275 298 1,467 1,146 Adjustments to reconcile net income to net cash flows from operating activities: Impairment and obsolescence 32 23 73 135 Depreciation and amortization 37 44 165 187 Deferred income taxes 25 (120) 63 (

  12. Slide 12: Balance sheets M€

    Balance sheets M€ Public Slide 12 Assets Dec 31st, 2011 Dec 31st, 2012 17 January 2013 Cash & cash equivalents and short-term investments 2,732 38% 2,698 36% Accounts receivable, net 881 12% 605 8% Finance receivables, net 79 1% 304 4% Inventories, net 1,625 22% 1,857 25% Other assets 545 7% 558 8%

  13. Slide 13: Bookings activity by sector, EUV not included

    Bookings activity by sector, EUV not included Public Slide 13 Total value M€ 667 17 January 2013 Net booked Foundry • 26 new tools at € 617 million 79% • 6 used tools at € 50 million Memory 18% IDM 3% Due to uncertainty around system allocations between DRAM and NAND we report total memory only Numb

  14. Slide 14: Backlog in value per Dec 31th, EUV not included

    Backlog in value per Dec 31th, EUV not included Public Slide 14 Total value M€ 1,214 17 January 2013 Region USA Technology (ship to location) 9% Japan 7% KrF 26% I-Line 2% Taiwan Singapore 9% 40% ArF dry 1% Europe 8% End-use China ArF immersion Foundry Korea 11% 71% 54% 16% 74% of backlog carries sh

  15. Slide 15: Capital return to shareholders

    Capital return to shareholders Public Slide 15 17 January 2013 • ASML proposes to again increase dividend by 15% to € 0.53 per ordinary share • For regulatory reasons, ASML will not announce any new share buy back program before Cymer’s shareholders meeting, dated 5 February 2013 • ASML returned mor

  16. Slide 16: Cymer merger update

    Public Slide 16 17 January 2013 Cymer merger update

  17. Slide 17: ASML - Cymer merger agreement status

    ASML - Cymer merger agreement status Public Slide 17 17 January 2013 • In Q4 2012, we announced the intended cash-and-stock acquisition of lithographic light source supplier Cymer • As part of the regulatory review process, clearance has been granted by the Committee on Foreign Investment in the Uni

  18. Slide 18: Business environment

    Public Slide 18 17 January 2013 Business environment

  19. Slide 19: Business environment

    Business environment Public Slide 19 17 January 2013 • Entering 2013 we plan for revenues to be at a similar level to 2012 driven by 28 and 20 nm logic • Slow Q1 start • Recovering in Q2 and a relatively large second half • Expect continued minimum investment level from the memory sector, generating

  20. Slide 20: ASML technology status

    Public Slide 20 17 January 2013 ASML technology status

  21. Slide 21: EUV progress encouraging

    EUV progress encouraging Public Slide 21 17 January 2013 • Demonstrated first fully integrated EUV source showing stable exposure power up to 40 Watts, good dose control, full field exposure over extended time, against a production target of 105 Watts • Source design was tested successfully at up to

  22. Slide 22: EUV deliveries and orders

    EUV deliveries and orders Public Slide 22 17 January 2013 • First NXE:3300B customer system is in final stage of test and qualification for shipment in Q2 • We target for a maximum of 11 potential shipments in 2013, representing a net sales value of around € 700 million • Current negotiations with 4

  23. Slide 23: Record sales from service and field options

    Record sales from service and field options Public Slide 23 17 January 2013 • Holistic Lithography adoption continues to expand • Performance enhancement products (productivity and overlay) as well as metrology, contribute to record sales from service and field options of € 257 million in Q4 and wil

  24. Slide 24: ASML's Holistic Lithography Solutions to drive future service and field options revenues

    ASML’s Holistic Lithograph Solutions to drives future service and Public field options revenues Slide 24 17 January 2013 ASML Scanner Wafer Track ASML Yieldstar Yieldstar metrology systems and Litho InSight software roadmap supports full integration to deliver improved On- Product Performance for 20

  25. Slide 25: Customer Co-Investment Program update

    Public Slide 25 17 January 2013 Customer Co-Investment Program update

  26. Slide 26: Update of Co-Investment Program

    Update of Co-Investment Program Public Slide 26 17 January 2013 • ASML intends to spend € 750 – 800 million in R&D in 2013 • Co-Investment participants are expected to contribute € 200 million in cash for R&D in 2013 • Co-Investment will contribute to: • Acceleration of EUV development of machines a

  27. Slide 27: Outlook

    Public Slide 27 17 January 2013 Outlook

  28. Slide 28: Q1 Outlook

    Q1 Outlook Public Slide 28 17 January 2013 • Net sales around € 850 million • Gross margin about 38 % • R&D costs of € 185 million, with other income from Co-Investment participants of € 16 million • SG&A costs of € 63 million, including € 6 million expenses related to pending Cymer acquisition ASML

  29. Slide 29: Reconciliation between GAAP and non-GAAP measures

    Reconciliation between GAAP and non-GAAP measures Public Slide 29 17 January 2013 Q3 12 Q4 12 2011 2012 Net cash provided by (used in) investing activities (240) 60 (301) (1,120) (GAAP) Net cash used to acquire ( provided by) short term 190 (110) 0 930 investments Net cash provided by (used in) inve

  30. Slide 30: ASML

    ASML

ASML — Q4 2012 Earnings Presentation on 6ix